Moreover, our findings also suggest that GRSF1 might be a novel diagnostic marker or even a new target for the prevention or treatment of age-associated hypercoagulability, cardiovascular, cerebrovascular, and thrombotic diseases. This evidence concerns the gene GRSF1 and thrombophilia.